Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells
H Taylor, SL Minger - Current opinion in biotechnology, 2005 - Elsevier
Cell replacement therapy has been proposed as a means of replacing specific populations
of cells lost through trauma, disease or ageing. Parkinson's disease is a progressive …
of cells lost through trauma, disease or ageing. Parkinson's disease is a progressive …
Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells
H Taylor, SL Minger - Current opinion in biotechnology, 2005 - pubmed.ncbi.nlm.nih.gov
Cell replacement therapy has been proposed as a means of replacing specific populations
of cells lost through trauma, disease or ageing. Parkinson's disease is a progressive …
of cells lost through trauma, disease or ageing. Parkinson's disease is a progressive …
Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells
H Taylor, SL Minger - Current Opinion in Biotechnology, 2005 - infona.pl
Cell replacement therapy has been proposed as a means of replacing specific populations
of cells lost through trauma, disease or ageing. Parkinson's disease is a progressive …
of cells lost through trauma, disease or ageing. Parkinson's disease is a progressive …
Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells.
H Taylor, SL Minger - Current Opinion in Biotechnology, 2005 - europepmc.org
Cell replacement therapy has been proposed as a means of replacing specific populations
of cells lost through trauma, disease or ageing. Parkinson's disease is a progressive …
of cells lost through trauma, disease or ageing. Parkinson's disease is a progressive …